RIO DE JANEIRO, BRAZIL - The Serum Institute, responsible for the production in India of the covid-19 vaccine developed by AstraZeneca and the University of Oxford, has informed Brazil that it will not be able to meet the delivery deadlines of the immunizers purchased by the Jair Bolsonaro government.
The information was published this Sunday, March 21st, by the Indian Times. According to the daily, the head of the institute, Adar Poonawalla, sent a letter to Fiocruz confirming the suspension of deliveries, without an exact date for resumption.
Brazil, according to Poonawalla, has so far received 4 million of the . . .